Pilot Investigation on Long-Term Subcutaneous Microdialysis: Proof of Principle in Humans
Journal Title: The AAPS Journal - Year 2013, Vol 15, Issue 1
Abstract
Reliable drug concentration measurements at the target site are increasingly demanded and can be achieved by microdialysis. The aim of this pilot study was to demonstrate the proof of principle of long-term subcutaneous microdialysis in humans. For long-term microdialysis, a special setting implementing both concentric and linear catheters has been developed ensuring good clinical practice compliance, tolerability, and convenience for participants and personnel. As a model compound, moderately lipophilic voriconazole was selected as a well-characterized drug in in vitro microdialysis experiments. Multiple in vivo relative recovery (RR) determinations for microdialysis were performed by retrodialysis during the entire study (n = 48 samples). Continuous microdialysis was successfully applied and well tolerated over 87 h in three adults for the first time. RR revealed low intra-individual (coefficient of variation (CV) = 4.4–12.5%) and inter-individual variability (CV = 4.3–12.5%) across all samples and catheters. Lower RR values were consistently determined for linear catheters. One catheter leakage was managed without an impact on the reliability of the RR values. Overall, RR values were calculated to be 73.3% (linear: CV = 18.5%, n = 23) and 84.9% (concentric: CV = 5.6%, n = 23). Long-term microdialysis application over almost 4 days was feasible by reliable multiple RR (proof of principle), well tolerated, and reduced the burden in humans avoiding several catheter insertions, thereby allowing to monitor concentration–time courses continuously. Moreover, a moderately lipophilic drug has been proven suitable for in vivo microdialysis, as previously suggested by in vitro microdialysis.
Authors and Affiliations
Franziska Simmel, Claudia Kirbs, Zeynep Erdogan, Edith Lackner, Markus Zeitlinger, Charlotte Kloft
Keywords
Related Articles
- EP ID EP681751
- DOI 10.1208/s12248-012-9412-z
- Views 105
- Downloads 0
Many Approved Drugs Have Bioactive Analogs With Different Target Annotations
The online version of this article (doi:10.1208/s12248-014-9621-8) contains supplementary material, which is available to authorized users.
Partial derivative—Based sensitivity analysis of models describing target-mediated drug disposition
Sensitivity analysis is commonly used to characterize the effects of parameter perturbations on model output. One use for the approach is the optimization of an experimental design enabling estimation of model parameters...
Combined Use of In Vitro Phototoxic Assessments and Cassette Dosing Pharmacokinetic Study for Phototoxicity Characterization of Fluoroquinolones
The present study aimed to develop an effective screening strategy to predict in vivo phototoxicity of multiple compounds by combined use of in vitro phototoxicity assessments and cassette dosing pharmacokinetic (PK) stu...
Drug inhibition of Gly-Sar uptake and hPepT1 localization using hPepT1-GFP fusion protein
An hPepT1-GFP fusion construct was made to study drug inhibition of dipeptide uptake and apical, basolateral, or subcellular hPepT1 localization. The hPepT1 stop codon was mutated by polymerase chain reaction and was sub...
ADME of Biologics—What Have We Learned from Small Molecules?
Thorough characterization and in-depth understanding of absorption, distribution, metabolism, and elimination (ADME) properties of a drug candidate have been well recognized as an important element in small molecule (SM)...